CARDIOCOMMAND, INC.
TAMPA, FLORIDA

Founded in 1994, CardioCommand, Inc., based at 4920 W Cypress St, Ste 110, Tampa, FL, is a private company known for its trailblazing work with temporary cardiac monitoring and pacing solutions. By using patented electronic devices combined with electrodes on catheters placed inside the esophagus, CardioCommand provides innovative transesophageal atrial pacing (TAP) systems. These systems are strategically positioned close to the heart's left atrium, enhancing noninvasive monitoring and treatment capabilities. Their groundbreaking products have been rigorously tested by over 20 top-tier institutions worldwide and now enjoy wide clinical acceptance among tens of thousands of patients globally. CardioCommand offers two main product lines: TAPSTRESS Systems for cardiac stress testing and electrophysiology work, and a specialized solution designed for anesthesiology/surgery that requires both cardiac pacing and ECG monitoring. These systems present significant benefits over traditional drug treatments and invasive techniques by reducing risks such as arrhythmias and adverse drug reactions while offering precise pacing. The company's focus spans Cardiology Electrophysiology Testing, Cardiology Stress Testing, and the Anesthesia/Surgery market segments, all bolstered by eight distinctive product advantages. Alongside its primary operations, CardioCommand extends its expertise through Contract Manufacturing Services in the medical device sector. Initially established as Synchrotech Medical Corporation and later known as Arzco Medical Systems, Inc., CardioCommand has grown under key leaders like Gerald Maass and Maynard Ramsey. For more information on what they offer or for corporate details, check out their website at [cardiocommand.com](http://cardiocommand.com).